Joshua J. Freemire, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Baltimore office, was quoted in Mergers & Acquisitions, in “How to Close a Deal in This Environment,” by Demetri Diakantonis. The article was also featured in M&A Today.
Following is an excerpt:
Feel like the diligence process around your deals is taking longer than usual? You’re not alone. Valuation gaps between buyers and sellers are just one reason why trying to close a mid-market deal is so difficult these days. Doing diligence on a deal is as complicated as ever when assessing risk and getting investment committees on board. What’s a dealmaker to do? We asked several experts for an assessment of the current environment and got their best advice on how to get a deal done right now. Here’s their analysis. …
Joshua Freemire, a member at Epstein Becker & Green, says buyers should be willing to accept more risks if they want to speed up diligence processes, and focus on the most “truly impactful items.”
“Moving fast will typically mean accepting more risk,” he says. “This can show up in higher level diligence or more compromises on reps, holdbacks and indemnities, but in either case it just means higher risk.”
